Volume 135, Issue 1, Pages (October 2014)

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

Volume 86, Issue 1, Pages (October 2014)

Volume 144, Issue 1, Pages (January 2017)

ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma Oncology - DOI: / Fig. 1. The immunohistochemical.

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.

L. Boyanova Clinical Microbiology and Infection

Volume 148, Issue 1, Pages (January 2018)

Volume 150, Issue 1, Pages (July 2018)

Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients O. Epaulard, C. Saint-Raymond,

Are patients willing to travel for better ovarian cancer care?

Volume 150, Issue 3, Pages (September 2018)

L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L

Volume 148, Issue 1, Pages (January 2018)

Volume 150, Issue 3, Pages (September 2018)

Pain in cancer survivors; filling in the gaps

Volume 145, Issue 2, Pages (May 2017)

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

Vulvar intraepithelial neoplasia: Risk factors for recurrence

Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer

Volume 141, Issue 2, Pages (May 2016)

M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns

Volume 151, Issue 1, Pages (October 2018)

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei

L.M. Bean, F.J. Sulzmaier, D.D. Schlaepfer

National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence J. Chino, J.R. Foote,

Prognostic Factors in Patients with Pathologic T1-2N1M0 Disease in Non-small Cell Carcinoma of the Lung Katsunari Matsuoka, MD, Shinichi Sumitomo, MD,

Volume 151, Issue 1, Pages (October 2018)

K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani

Volume 152, Issue 1, Pages (January 2019)

Volume 143, Issue 2, Pages (November 2016)

Laparoscopic staging for stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base A. Melamed, J.T. Clemmer, N.L. Keating, J.D. Wright,

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M

Curtailed short-term and long-term survival following infection with non-typhoid Salmonella in Israel M. Weinberger, S. Yaron, V. Agmon, R. Yishai, A.

Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates N.A. Latif, E.M. Ko,

Volume 130, Issue 1, Pages (July 2013)

Long-term mortality following bloodstream infection

Volume 152, Issue 1, Pages (January 2019)

Volume 147, Issue 1, Pages (October 2017)

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Volume 152, Issue 1, Pages (January 2019)

Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK , an AKT inhibitor, in patients with recurrent or persistent.

Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases

Volume 130, Issue 3, Pages (September 2013)

Survival Differences by Gender for Resected Non-small Cell Lung Cancer: A Retrospective Analysis of 12,509 Cases in a Japanese Lung Cancer Registry Study

Volume 4, Issue 5, Pages 2-3 (October 2006)

The complex interaction of cancer surgery, complications, and patient-reported outcomes: A single score is not enough K.M. Doll, E.L. Barber, J.T. Bensen,

Volume 142, Issue 2, Pages (August 2016)

Annika Idahl, Andrea Hermansson, Ann Lalos Gynecologic Oncology

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study

High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.

Volume 17, Issue 2, Pages (February 1950)

Volume 152, Issue 1, Pages (January 2019)

Renal Pyelocalyceal Squamous Cell Carcinoma

Full inguinofemoral lymphadenectomy after positive sentinel inguinofemoral lymph node is associated with greater overall survival in patients with stage.

Volume 152, Issue 1, Pages (January 2019)

Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.

Volume 151, Issue 1, Pages (October 2018)

Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer M. Dandapani, B.L. Seagle, R. Samuelson,

Volume 130, Issue 1, Pages (July 2013)

Carcinoma of the esophagus: Prognostic significance of histologic type

Characteristics of primary peritoneal serous carcinoma in a U. S

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.

Volume 147, Issue 3, Pages (December 2017)

Volume 82, Issue 9, Pages (November 2012)

Jan Roigas European Urology Supplements

Should ovarian preservation be considered for women younger than 60 years with endometrial carcinoma? L.M. Bean, K. Taylor, K.M. Anderson, M.A. Davis,

Volume 163, Issue 2, (October 2015)

Volume 115, Issue 1, Pages (October 2009)

Presentation transcript:

Volume 135, Issue 1, Pages 149-155 (October 2014) CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma Marjolijn D. Trietsch, Vivian M. Spaans, Natalja T. ter Haar, Elisabeth M. Osse, Alexander A.W. Peters, Katja N. Gaarenstroom, Gert Jan Fleuren Gynecologic Oncology Volume 135, Issue 1, Pages 149-155 (October 2014) DOI: 10.1016/j.ygyno.2014.07.094 Copyright © 2014 The Authors Terms and Conditions

Fig. 1 Mutation spectrum. Mutation spectrum for 107 VSCC patients. Medium grey=wild type or non-infected. Dark grey=mutated or infected. Lightest grey=assay failed. Gynecologic Oncology 2014 135, 149-155DOI: (10.1016/j.ygyno.2014.07.094) Copyright © 2014 The Authors Terms and Conditions

Fig. 2 Survival curves. Overall survival, P=.035 (left), and disease-specific survival, P=.058 (right) for 107 vulvar squamous cell carcinoma patients in this study. Upper line (grey)=no mutation detected; lower line (black)=mutation detected. Gynecologic Oncology 2014 135, 149-155DOI: (10.1016/j.ygyno.2014.07.094) Copyright © 2014 The Authors Terms and Conditions